Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists

PURPOSE: To provide pharmacists with information on counseling patients with type 2 diabetes (T2D) receiving oral semaglutide. SUMMARY: Oral semaglutide, the first oral glucagon-like peptide 1 (GLP-1) receptor agonist (GLP-1RA), was approved for the treatment of adults with T2D by the US Food and Dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kane, Michael P, Triplitt, Curtis L, Solis-Herrera, Carolina D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970404/
https://www.ncbi.nlm.nih.gov/pubmed/33354706
http://dx.doi.org/10.1093/ajhp/zxaa413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970404/
https://www.ncbi.nlm.nih.gov/pubmed/33354706
http://dx.doi.org/10.1093/ajhp/zxaa413

Ejemplares similares